Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.

NCT: NCT06470022 · RECRUITING

NCT IDNCT06470022
StatusRECRUITING
Start Date2024-08-09
Completion2036-12-01

Brief Summary

To compare outcome in patients randomized to treatment with Evolut FX versus Sapien 3 Ultra Resilia.

Frequently Asked Questions

What is Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.?

Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. is a clinical trial registered under NCT06470022. Current status: RECRUITING.

What is the status of NCT06470022?

The current status of NCT06470022 (Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.) is: RECRUITING.

When did Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. start?

Comparison of Evolut FX Versus Sapien 3 Ultra Resilia. started on 2024-08-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑